CABOMETYX

ipsen biopharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: e032ee984c65b6bf
Drug Approval Canada Name: CABOMETYX
Product Name: CABOMETYX
Status: Marketed
Status Date: 2018-10-10
Original Market Date: 2018-10-10
Din: 02480824
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EX07 CABOZANTINIB
Atc Name: l 01 ex 07
Aig Number: 0160650001
Company Name: ipsen biopharmaceuticals canada inc
Company Address: SUITE 500, 5050 Satellite Drive, Mississauga, Ontario, Canada, L4W 0G1

CABOZANTINIB (CABOZANTINIB MALATE)

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e032ee984c65b6bf

Type

Standard